跳至主要内容
临床试验/NCT07307040
NCT07307040尚未招募不适用

Construction of a Precision and Individualized Management Model for Diabetes With Integrated Traditional Chinese and Western Medicine

Peking Union Medical College Hospital0 个研究点目标入组 2,000 人开始时间: 2025年12月31日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
2,000
主要终点
Traditional Chinese Medicine Syndrome Score

研究概览

简要总结

This project will leverage a large-scale cohort of early-onset type 2 diabetes patients to conduct innovative prospective clinical research. By integrating traditional Chinese medicine diagnostic information, clinical data, laboratory results, continuous glucose monitoring, genetic information, multi-omics data, and multi-modal monitoring data, and utilizing advanced data analysis methods such as deep learning, the project aims to establish a comprehensive monitoring, precise classification, and personalized diagnosis and treatment model-a holistic management approach integrating traditional Chinese and Western medicine for early-onset type 2 diabetes. This initiative is expected to enhance the management of early-onset type 2 diabetes, improve treatment outcomes and quality of life for affected patients, pioneer an innovative path for personalized integrated traditional Chinese and Western medicine management in this population, and promote the application of precision medicine in diabetes prevention and treatment.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • The age at diabetes diagnosis is ≥18 years but <40 years.

排除标准

  • The clinical diagnosis was type 1 diabetes, and at the time of enrollment, antibody levels or insulin/C-peptide results still supported the original diagnosis.
  • There were clear secondary factors contributing to hyperglycemia, such as Cushing's syndrome or pheochromocytoma.

结局指标

主要结局

Traditional Chinese Medicine Syndrome Score

时间窗: Through study completion, an average of 3 months

HbA1c

时间窗: Through study completion, an average of 3 months

次要结局

  • Triglycerides(Through study completion, an average of 3 months)
  • High-Density Lipoprotein Cholesterol(Through study completion, an average of 3 months)
  • Total Cholesterol(Through study completion, an average of 3 months)
  • Fasting Blood Glucose(Through study completion, an average of 3 months)
  • Low-Density Lipoprotein Cholesterol(Through study completion, an average of 3 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Xinhua Xiao

Chief physician

Peking Union Medical College Hospital

相似试验